story of the week
Empagliflozin in Patients With CKD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Empagliflozin in Patients with Chronic Kidney Disease
N. Engl. J. Med 2022 Nov 04;[EPub Ahead of Print], WG Herrington, N Staplin, C Wanner, JB Green, SJ Hauske, JR Emberson, D Preiss, P Judge, KJ Mayne, SYA Ng, E Sammons, D Zhu, M Hill, W Stevens, K Wallendszus, S Brenner, AK Cheung, ZH Liu, J Li, LS Hooi, W Liu, T Kadowaki, M Nangaku, A Levin, D Cherney, AP Maggioni, R Pontremoli, R Deo, S Goto, X Rossello, KR Tuttle, D Steubl, M Petrini, D Massey, J Eilbracht, M Brueckmann, MJ Landray, C Baigent, R HaynesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.